
COVID-19 has accelerated the adoption of telehealth, but digital therapeutics, diagnostics and remote patient monitoring are predicted to play a more significant role moving forward, says Liz Ashall-Payne, founder and CEO of ORCHA.
Videos from healthcareitnews.com
